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The inflammasome is a major component of the innate
immune system, and its main function is to activate caspase-1, a
cysteine protease that promotes inflammation by inducing
interleukin-1 (IL-1)maturation and release into the extracel-
lular milieu. To prevent uncontrolled inflammation, this com-
plex is highly regulated. When it is assembled, the inflam-
masome is insoluble, whichhas long precluded the analysis of its
interactions with other proteins. Here we used the proximity-de-
pendent biotinylation assay (BioID) to identify proteins associated
with caspase-1 during inflammasome activation. Using the BioID
in a cell-free system in which the inflammasome had been acti-
vated,we found that a caspase-1–biotin ligase fusionprotein selec-
tively labeled 111 candidates, including the p62/sequestosome-1
protein (p62). Using co-immunoprecipitation experiments, we
demonstrated that p62 interacts with caspase-1. This interaction
promoted caspase-1–mediated cleavage of p62 at Asp-329.Mech-
anistic and functional analyses revealed that caspase-1–mediated
cleavage of p62 leads to loss of its interaction with the autophago-
somal protein microtubule-associated protein 1 light chain 3 
(LC3B). Strikingly, overexpression of a p62 N-terminal fragment
generated upon caspase-1 cleavage decreased IL-1 release,
whereas overexpression of p62’s C-terminal portion enhanced
IL-1 release, by regulating pro-IL1 levels. Overall, the overex-
pression of both fragments together decreased IL-1 release.
Taken together, our results indicate that caspase-1–mediated p62
cleavage plays a complex role in balancing caspase-1–induced
inflammation.
Caspase-1 is essential for processing and maturing pro-
inflammatory cytokines; namely, interleukin-1 (IL-1)3 and
IL-18 (1). Caspase-1 is found in cells as an inactive precursor
and is activated in response to inflammatory signals, including
pathogen-associated molecular patterns and damage-associated
molecular patterns. Following the recognition of pathogen-as-
sociated molecular patterns or damage-associated molecular
patterns, a subset of intracellular pattern recognition receptors
assembles into a macromolecular complex known as the
inflammasome (2, 3). Most inflammasome pattern recognition
receptors belong to the family of nucleotide-binding domain and
leucine-rich repeat–containing receptors (NLRs). Caspase-1 acti-
vation takes placewithin inflammasomecomplexes. In addition to
triggering IL-1/IL-18 activation and release, active caspase-1 ini-
tiates an inflammatory form of cell death termed pyroptosis (4).
Caspase-1 and caspase-11 (the latter being themurine ortholog of
humancaspases4and5)cleavegasderminD(GSDMD), leading to
the release of theGSDMDN terminus polypeptide that oligomer-
izes in the plasma membrane, leading to pore formation and
rupture of the plasmamembrane (5, 6). The resulting disrup-
tion of plasma membrane integrity leads to osmotic swelling
and release of inflammatory cytokines and culminates in
pyroptotic cell death.
The inflammasome is a well-controlled machinery. Various
mechanisms preventing its activation are known, and some
competitive inhibitors have also been described, such as pyrin-
only proteins or card-only proteins (7). Moreover, inflam-
masome activation does not always end in inflammatory cell
death, and some processes may terminate its activation (8–11).
Autophagy is an intracellular degradation system associated
with maintenance of cellular homeostasis. Autophagy plays a
critical role in inflammasome regulation (8, 11). First, autophagy
suppresses TLR4-dependent production of IL-1 and IL-18 by
inhibiting TRIF-dependent reactive oxygen species production
(12). Second, autophagy suppresses activation of the NLRP3
inflammasome by eliminating damaged mitochondria, thus
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preventing excess production of reactive oxygen species and
mitochondrial DNA, in a process called mitophagy (13).
Mitophagy depends on the adaptor p62/SQSTM1 (hereafter
called p62) (14). Finally, autophagy selectively eliminates ubiq-
uitinated ASC and IL-1. Indeed, p62 targets these inflam-
masome components to the LC3B-positive cytosolic compart-
ment, allowing their engulfment into autophagosomes and
their elimination in autophagolysosomes.
In this study, we took advantage of the proximity-dependent
biotinylation assay coupled with MS (BioID) to identify caspase-
1–neighboring proteins during inflammasome activation (15).
This BioID–caspase-1 assay identified 111 proteins, indicating
that these candidates were in close proximity of caspase-1 but not
necessary interactors.
Of these potential candidates, 28 (25%) had previously been
linked to the inflammasome complex or autoinflammation.
Among the hits, p62 was confirmed to interact with caspase-1
and identified as a new caspase-1 substrate. We demonstrate
that caspase-1–mediated p62 cleavage at Asp-329 prevents
its interaction with LC3B. Moreover, overexpression of p62
cleaved fragments regulates IL-1 release, suggesting that p62
is a complex regulator of the inflammasome.
Results
Expression of BirA*–caspase-1 in caspase-1/macrophages
The analysis of inflammasome component interactions with
other proteins has long been challenged by the insoluble nature
of the complex. To overcome this technical issue, we used
BioID, a method based on proximity-dependent biotinylation
of proteins that are near neighbors of a fusion protein directly
within cells or cell lysates. Biotinylated proteins can then be
identified using streptavidin affinity capture and MS. The
advantage of this approach is that the affinity capture can be
performed under stringent conditions that disrupt native com-
plexes and limit pulldown contaminants. In this system, the
targeting protein is fused to a 35-kDa DNA-binding biotin pro-
tein ligase derived from Escherichia coli and called BirA (16). A
BirAmutant (R118G, hereafter calledBirA*) is defective in both
self-association and DNA binding and has enhanced capacity
for proximity-dependent biotin ligation (17). In addition, bioti-
nylation is an exceptional endogenous modification in mam-
malian cells (18). To identify proteins in the vicinity of
caspase-1 during inflammasome activation, we expressed a
BirA*–caspase-1 fusion protein under an inducible promoter
in immortalized bone marrow-derived macrophages (iBMDMs)
derived from caspase-1/mice (Fig. 1). Full caspase-1 activa-
tion is associated with its cleavage within the inflammasome
complex, and the half-life of processed caspase-1 is very short
(2, 19). To increase the sensitivity of the system, we fused the
BirA* ligase to amutated caspase-1 containing aQ281H substi-
tution within the catalytic site and observed no degradation of
BirA*–caspase-1 after 6 h of inflammasome activation in a
cell-free inflammasome-activating assay (Fig. 1, A and B). In
this cell-free system, disruption of the cell membrane, along
with hypotonic and low-potassium conditions, spontane-
ously activates the inflammasome (20). We then verified that
inflammasome oligomerization was not altered by the BirA*
fusion protein by assaying apoptosis-associated speck-like
protein containingaCARD(ASC)oligomerization in thecell-free
system. As expected, ASC oligomerization was preserved under
inflammasome-activating conditions in reconstituted cells using
the cell-free system (Fig. 1C) or in intact cells treated with the
inflammasome activator nigericin (Fig. 1D)
Identification of proteins in the vicinity of caspase-1 during
inflammasome activation in a cell-free assay
Studying inflammasome activation in cytosolic extracts pro-
vides multiple advantages, as it is synchronized, rapid, and
strong. We thus decided to use this system to identify the rep-
ertoire of proteins coming in close proximity with caspase-1
during inflammasome activation. Doxycyclinewas added to the
cells to induce BirA*–caspase-1 expression 24 h before the
experiment. Cells were then mechanically lysed in a hypotonic,
low-potassium buffer at 4 °C and incubated at 37 °C for 6 h in
the presence of biotin (Fig. 2A). Control cells were left at 4 °C to
prevent inflammasome activation. Biotinylated proteins were
subsequently captured with streptavidin-coupled beads and
extensively washed, and bound proteins were analyzed by MS.
Because ASC is the main caspase-1–interacting protein during
inflammasome activation, streptavidin pulldown of ASC was
selected as the readout for a successful procedure before MS
analysis (Fig. 2B).
Proteins unique to the BioID–caspase-1 (BirA*–caspase-1)
pulldown and not detected with identical pulldowns from
control cells (no doxycycline) were then selected based on an
enrichment factor of 2 during inflammasome activation. As
expected, MS identified ASC and caspase-1. Furthermore,
caspase-1 was the most abundantly identified protein, detected
at similar levels before and after inflammasome activation. Self-
biotinylation of the bait protein explains this result. Among the
1108 proteins identified by MS, 480 were not detected in con-
trol cells (without doxycycline). 368 of 480 (77%) had an enrich-
ment factor of 2 (Fig. 2C, left panel) upon inflammasome
activation (37 °C versus 4 °C). We then removed 146 proteins
that were contained in the Contaminant Repository for Affinity
Purification (www.crapome.org;4 47) because they are known
as usual contaminants of streptavidin-based affinity capture.
This selection resulted in a final number of 111 proteins.
Importantly, 28 proteins (25%) had previously been linked to
the inflammasome complex or autoinflammation (Table S1),
validating our screen to identify inflammasome-related pro-
teins. Gene ontology enrichment analysis revealed significant
enrichment in proteins involved in the regulation of NF-B
signaling (fold enrichment, 9.23; p 0.01), in the regulation of
vesicle-mediated transport (fold enrichment, 6.59; p  0.001),
in the regulation of protein transport (fold enrichment, 3.87;
p  0.001), and in metabolic processes (fold enrichment, 2.33;
p 0,01) (Fig. 2C, right panel).
Caspase-1 interacts with p62
In our BioID–caspase-1 screen, we identified caspase-1
proximity biotinylation of p62 (three unique peptides), a
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party–hosted site.
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major adaptor protein involved in selective autophagy. p62
mainly serves as a cargo to drive ubiquitinated proteins to
the LC3B-positive autophagosome before selective degrada-
tion within the autophagolysosome (21, 22). The func-
tion of the protein requires its complete integrity (23).
p62 is also implicated in cell survival, inflammation, and
osteoclastogenesis through its interactions with TRAF6/
RANK/NF-B and in apoptosis by scaffolding ubiquitinated
caspase-8 (22).
We demonstrated the interaction between caspase-1 and p62
by performing a co-immunoprecipitation in HEK293T trans-
fectedwith plasmids expressing FLAG-tagged caspase-1 andHA-
tagged p62 (Fig. 3A). In addition, inflammasome activation in
primary human macrophages using LPS nigericin treatment
led to the formation of caspase-1 specks corresponding to the
inflammasome complex that colocalized with p62 (Fig. 3B). In
contrast, upon LPS priming alone, p62 and caspase-1 had
cytosolic localization but did not show any obvious colocaliza-
tion, suggesting that p62 interacts specifically with caspase-1
upon inflammasome assembly.
Caspase-1 cleaves p62 at Asp-329
We then found that the inflammasome activation in a THP-
1–derived cell-free system resulted in p62 cleavage and appear-
ance of a 30-kDamigrating fragment (Fig. 4A). To further assess
whether the cleavage of p62 depended on caspase-1, we used
another model of inflammasome activation in the presence or
absence of specific inhibitors. Inflammasome activation in pri-
mary humanmonocytes resulted in the cleavage of p62, and this
cleavage was prevented by addition of Z-YVAD, a caspase-1
inhibitor (Fig. 4B). In contrast, the addition of specific inhibi-
tors of caspase-8 (Z-IETD) or calpain, two proteases known for
their ability to cleave p62 (24), did not prevent this cleavage.We
further confirmed that caspase-1 was sufficient to cleave p62 by
Figure 1. Generation of HA-tagged BirA*–caspase-1–overexpressing macrophages. A, schematic showing caspase-1 WT (casp-1 WT) and the
engineeredQ281H-mutated caspase-1 fused to HA-tagged BirA* (casp-1*-BirA). B, immortalized bonemarrow-derivedmacrophages from Caspase-1/
mice were reconstituted with a doxycycline (Dox)-inducible casp-1*-BirA (iCasp-1*-BirA). Reconstituted cells (KO-iCasp-1*-BirA) and their WT or caspase-
1/ (KO) controls were plated in the presence or absence of doxycycline (1 g/ml) and incubated for 24 h. Cells were harvested, centrifuged, and
resuspended in a hypotonic low-potassium buffer at 4 °C. Cells weremechanically lysed, and nuclei and plasmamembranes were removed. The cell-free
preparation was then incubated at 37 °C for 6 h (T6) or not (T0). Proteins were analyzed by Western blotting after boiling and fractionating on a 10%
SDS-polyacrylamide gel. C, ASC oligomerization was analyzed after cross-linking or not with DSS and analyzed by Western blotting under nonreducing
conditions. D, ASC oligomerization was also verified in cells previously plated in the presence of doxycycline upon activation of the inflammasome by
LPS (1 g/liter, 3 h) nigericin (5 M, 45 min). ASC oligomers were cross-linked or not with DSS and analyzed by Western blotting under nonreducing
conditions.
p62/SQSTM1 is a caspase-1 substrate
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cotransfecting HEK293T cells with plasmids encoding p62 and
various caspases (Fig. 4C). HEK293T cells lack the inflam-
masomemachinery (25), but the ectopic expression of caspases
is sufficient to obtain their self-activation. In this experiment,
we confirmed that caspase-1 was very efficient in cleaving p62
compared with other caspases. In addition, we also detected
Figure 2. Identification of caspase-1–neighboring proteins during inflammasome activation in a cell-free assay. A, schematic presenting the
BioID approach adapted to the cell-free assay for inflammasome activation. B, reconstituted cells (KO-iCasp-1*-BirA) and their WT or Caspase-1/ (KO)
controls were plated in presence or absence of doxycycline (Dox, 1 g/ml) and incubated for 24 h. Cells were harvested, centrifuged, and resuspended
in a hypotonic low-potassium buffer at 4 °C. Cells were mechanically lysed, and nuclei and plasma membranes were removed. The cell-free soup was
then incubated at 37 °C for 6 h (T6) or not (T0). Supernatants were then incubatedwith streptavidin-coated beads overnight at 4 °C. Beadswere collected
and rigorously washed. Streptavidin-bound proteins were then analyzed by Western blotting after boiling and fractionating on a 15% SDS-polyacryl-
amide gel. ASC pulldown was selected as the readout for successful procedure before MS analysis. IP, immunoprecipitation. C, sorting process of the
proteins identified by the caspase-1 BioID assay (1108 proteins were identified by MS, 628 were present in the uninduced sample, 112 proteins did not
pass the 2 enrichment threshold between the 37 °C and the 4 °C samples, and 146 proteinswere excluded based on CRAPome analysis, resulting in 111
proteins identified with confidence in the caspase-1 BioID assay). These candidates were analyzed for gene ontology (GO) enrichment according to
biological process (PANTHER classification system).
Figure 3. p62 interacts with caspase-1 upon inflammasome activation. A, HEK293T cells were transfected with plasmids encoding FLAG-tagged WT
caspase-1 and HA-tagged p62 and incubated overnight. Cells were detached, lysed, and centrifuged. Supernatants were then incubated for 3 h at 4 °C with
anti-FLAG–or anti-HA–agarose beads. Beadswere collected andwashed. Boundproteinswere analyzedbyWestern blotting after boiling and fractionating on
a 10% SDS-polyacrylamide gel. IP, immunoprecipitation. B, primary human monocyte-derived macrophages were treated as indicated. Cells were fixed,
permeabilized, and incubated with the indicated antibodies, and images were collected using a confocal microscope.
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cleavage of p62 by the pro-inflammatory caspase-4, an ortholog
of the murine caspase-11. In agreement with a previous report,
we observed that caspase-8 also induced degradation of p62
through multiple cleavage sites (24).
According to the molecular weight of the fragments and the
amino acid sequence, caspase-1–mediated cleavage of human
p62 was predicted to be at Asp-329 or Asp-347. We thus gen-
erated p62 expression constructs harboring the point muta-
tions p.[D329A] and p.[D347A] to interrogate the contribution
of the corresponding residues to caspase-1–mediated p62 pro-
cessing. HEK293T cells were cotransfected with caspase-1 and
theWT or the mutated p62 constructs. The cleavage of p62 by
caspase-1 was no longer detected in D329A-mutated p62 but
unaffected in the mutant carrying the p.[D347A] mutation
(Fig. 4D). The p.[D329A] mutation did not prevent the inter-
action between caspase-1 and p62, suggesting that the resi-
Figure 4. Caspase-1 cleaves p62 at Asp-329. A, p62 cleavage in THP-1 cells was assayed using the cell-free system. The inflammasome was activated by
incubating the cell-free soup at 37 °C during 1 h or 2 h in the presence or absence of pancaspase inhibitor (Z-VAD) or caspase-1 inhibitor (Z-YVAD). Caspase-1
(casp-1) andp62were thenanalyzedbyWesternblotting after boiling and fractionatingona10%SDS-polyacrylamidegel.Casp-1 p20 is the cleavage fragment,
observed when caspase-1 is activated. B, primary human monocytes, obtained from whole blood of healthy donors, were incubated in the presence of the
inflammasome activator (LPS and nigericin) with or without caspase-8 inhibitor (Z-IETD), calpain inhibitor, and caspase-1 inhibitor (Z-YVAD). Cells were then
washed and lysed, and p62 cleavage was analyzed by Western blotting after boiling and fractionating on a 10% SDS-polyacrylamide gel. Ratios of cleaved/
uncleaved p62 were calculated using ImageJ. C, HEK293T cells were co-transfected with plasmids encoding p62 and various caspases (casp-1 to 9) and
incubated overnight. Cells were then washed and lysed, and p62 and IL-1 were analyzed by Western blotting after boiling and fractionating on a 10%
SDS-polyacrylamidegel.D, HEK293T cellswere co-transfectedwithplasmids encodingWTcaspase-1 andWTormutatedp62containingpointmutations at the
indicated amino acids and incubated overnight. Cells were thenwashed and lysed, and p62 and caspase-1 expression and cleavagewere analyzed byWestern
blotting. E, HEK293T cells were co-transfectedwith plasmids encoding FLAG-taggedWT caspase-1 andWTormutated p62. Cells were thenwashed, lysed, and
incubated with anti-FLAG–agarose during 3 h at 4 °C. Beads were then rigorously washed, and bound proteins were analyzed by Western blotting. IP,
immunoprecipitation.
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due at Asp-329 is directly targeted by caspase-1 proteolytic
activity and does not contribute to p62 interaction with
caspase-1 (Fig. 4E).
Caspase-1 cleavage disrupts p62 interaction with LC3B and
modulates IL-1 secretion
Autophagy is known to regulate the inflammasome, and p62
has been shown to deliver ASC and IL-1 to the autophago-
some, resulting in suppression of inflammasome activation (8,
26). In addition, mice and cells deficient for p62 show higher
IL-1 release upon inflammasome activation (8, 27).We sought
to determine the role of p62 cleavage by caspase-1 on its inter-
action with LC3B and on IL-1 secretion. p62 is composed of
sixdomains, including anN-terminalPB1domain foroligomer-
ization, a ubiquitin-binding domain (UBA), and an LC3B-inter-
acting domain (LIR) (21, 22) (Fig. 5A). p62 interacts with the
autophagosome docking protein LC3B via its LIR domain to
shuttle ubiquitinated proteins into newly formed autophago-
somes (21). Furthermore, the cleavage of p62 at Gly-241 by a
protease from Coxsackievirus results in the disruption of p62
function in selective autophagy (23, 28). More precisely, the
C-terminal fragment retained the binding activity to LC3B and
exhibited a dominant-negative effect against native p62, prob-
ably by competing for LC3B binding. Because p62 self-oligo-
merization is required for ubiquitinated protein engulfment in
autophagosomes (22, 29), we tested whether this ability was
retained in both N-terminal and C-terminal fragments.
Although cotransfection of plasmids encoding full-length p62
and N-terminal p62 showed that the oligomerization ability
was retained for the N-terminal fragment, we did not observe
any interaction between full-length p62 and the p62C-terminal
fragment (Fig. 5B), suggesting that this fragment had lost the
ability to promote p62 oligomerization. In addition, we found
that the N-terminal fragment mediated the interaction of
caspase-1 with p62, whereas the LC3B-binding ability was lim-
ited to the C-terminal fragment (Fig. 5C). Altogether, these
results suggest that cleavage of p62 by caspase-1 may disrupt
p62 cargo function (Fig. 5D). To further characterize the func-
tional consequences of the cleavage, we transduced WT
iBMDMs with an inducible lentiviral vector encoding either of
the two cleaved fragments of p62.We then activated theNLRP3
inflammasomewith nigericin,MSU, orATP.Wedemonstrated
that ectopic expression of the N-terminal fragment of p62
decreased the release of IL-1 upon inflammasome activation,
whereas overexpression of the C-terminal fragment signifi-
cantly increased IL-1 release (Fig. 5E).
Because ectopic expression of the N- and C-terminal frag-
ments of p62 has inverse effects on IL-1 release, we assessed
the functional impact of co-expression of the two fragments.
We thus transduced WT iBMDMs with different ratios (1:1,
5:1, and 1:5) of lentiviral vectors encoding the N- or C-terminal
fragments of p62. Upon activation of the inflammasome by
ATP or nigericin, we observed a decrease in IL-1 secretion in
cells expressing high p62 N-terminal fragment levels, whereas
IL-1 secretion was increased in cells expressing high p62
C-terminal fragment levels (Fig. 5F and Fig. S1). These results
thus recapitulated the above findings. Nevertheless, when cells
expressed both the N- and C-terminal fragments with an iden-
tical ratio (1:1), the overall effect was inhibition of IL-1 secre-
tion, suggesting a negative dominant effect of the N-terminal
over the C-terminal fragment.
Autophagy has been reported to control IL-1 secretion by
targeting pro-IL-1 for degradation (26). We thus measured
the levels of pro-IL-1 and two other inflammasome compo-
nents, ASC and caspase-1, in the lysates of transduced cells.We
observed increased levels of pro-IL-1 in p62 C-terminal
fragment–expressing cells. Conversely, the levels of ASC and
pro-caspase-1 in untreated cells, LPS-treated cells, and
LPSATP-activated cells were not affected by p62 fragments
expression (Fig. S2). The increase in pro-IL-1 level was not
observed in WT and p62 N-terminal fragment–expressing
cells. This may, at least in part, explain the increased levels of
IL-1 secreted in C-terminal fragment–expressing cells after
inflammasome activation. Altogether, these findings indicate
that p62 is a complex regulator of the inflammasome and that
the two fragments cleaved by caspase-1 may differentially reg-
ulate IL-1 release.
Discussion
In this study, we took advantage of the recently described
BioID assay to identify caspase-1–neighboring proteins during
inflammasome activation. TheBioID assay consists ofMS iden-
tification of proteins that have been biotinylated by the BirA
proximity-dependent biotin ligase fused to a “bait” protein fol-
lowing streptavidin affinity capture (15). One limitation of the
BioID assay is the problem of scale when dealing with low-
abundance proteins. Such proteins may be difficult to identify,
and a sufficient start material is necessary. Indeed, in prelimi-
nary setup experiments, we were not able to detect robust ASC
biotinylation upon inflammasome stimulation in whole cells.
We have thus chosen to use the previously described cell-free
assay, where inflammasome assembly is very robust and occurs
spontaneously upon disruption of cellular integrity in a low-
potassium buffer (20). We assume that this method precludes
the identification of various proteins usually contained in cell
compartments that have been removed during the cell-free
preparation, such as the cell membrane or nuclear proteins.
Nevertheless, using the cell-free assay offers number advan-
tages: strong, rapid, and synchronized inflammasome activa-
tion alongwith a large quantity of proteins in a reduced volume.
The analysis of inflammasome component interactions with
other proteins has long been prevented by the insoluble nature
of the inflammasome when in its mature complex. The use of
the BioID assay sidesteps issues associated with bait protein
solubility because biotinylation occurs before protein solubili-
zation (15). Neighboring proteins are covalently modified with
biotin, and robust lysis conditions can be used to solubilize
polypeptides localized to poorly soluble cellular compartments.
Another limitation of BioID relies on the expression of an
exogenous protein that is fused to BirA* that may modify the
protein structure, assembly properties, and targeting (15). In
our study, we chose to fuse BirA* to a mutated caspase-1
(Q281H) to avoid protein degradation and a possible toxicity
associated with overexpression of the catalytically active
caspase-1 (Fig. 1, A and B). This strategy allowed the accumu-
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lation of caspase-1 without disrupting ASC oligomerization
(Fig. 1, D and E) and ASC–caspase-1 interaction (Fig. 2B).
The BioID identified 1108 candidates, of which 480 were not
detected with identical pulldowns from control cells. Upon
inflammasome activation, 368 were enriched with a factor of
2.Wemade a final sort by using the Contaminant Repository
for Affinity Purification (www.crapome.org;4 47) and identified
111 proteins interacting with/in the vicinity of caspase-1. This
strategy is debatable because it could have excluded caspase-1
interactors at steady state and proteins that are usual contami-
nants but would still be relevant caspase-1 interactors. Indeed,
many proteins involved in cell metabolism, such as glycolysis
(30), have been excluded from the analysis based on their
known tendency to contaminate streptavidin affinity capture
assays (www.crapome.org;4 47). Because our strategy was an
exploratory approach, and given that the BioID was not
intended to be used as a quantitative approach, we voluntarily
chose to be less specific to gain sensibility and to perform a
second step of validation for candidate proteins identified in the
BioID assay.
Interestingly, we identified 28 (25%) proteins that had previ-
ously been associated with either caspase-1 or the inflammasome
or autoinflammatory phenotypes inmice or humans (30–34). For
instance, we identified phospholipase-C2 (PLCG2), which has
been recently related to a novel human autoinflammatory disease,
PLCG2-associated antibody deficiency and immune dysregula-
tion (PLAID) (35). The pathophysiological mechanisms linking
PLCG2 structural anomalies and the autoinflammatory pheno-
type are being uncovered (36), but a direct interaction between
caspase-1 and PLCG2 has never been reported before. In our
BioID screen, we also identified cytoplasmic phospholipase A2
(cPLA2), an enzyme that had been previously demonstrated to be
a substrate of several caspases, including caspase-1 (37, 38). cPLA2
is believed to be involved in the “eicosanoid storm” accompanying
inflammasome activation, a crucial link between the inflam-
masome and inflammatory lipids (39). As for now, most of the
identified caspase-1 substrates have been related to caspase-1–
induced cell death. Accumulating evidence suggests that
caspase-1may also play a role in other innate immunity-related
pathways. For example, caspase-1 cleaves and dampens cGAS-
STING–mediated interferon production (40). Thus, looking at
caspase-1 interactors/substrates that are not involved in cell
death may reveal additional functions for caspase-1.
Our screen did not identify known caspase-1 substrates, such
as IL-1, IL-18, or GSDMD. For IL-1, this result was expected
because we did not use any priming step, which is necessary to
induce detectable pro-IL1 within the cytosol. BirA* may have
precluded conformational changes necessary to caspase-1
interactions with some of its substrates (19). Finally, the cell-
free assay process may have removed some proteins that asso-
ciate with organelles and the cell membrane.
Our screen identified p62 as a caspase-1–neighboring pro-
tein, and subsequent analyses revealed that p62 was also one of
its substrates.While going on with further analysis, we demon-
strated that p62 was cleaved by caspase-1 at Asp-329. Interest-
ingly, this aspartate residue is conserved among mammalian
species, except inMus musculus, where it is replaced by a gly-
cine residue. This difference may suggest different regulatory
functions for p62 between mice and humans or an alternative
cleavage site in mice. Interestingly, a large number of human
inflammasome regulators (e.g. card-only proteins and pyrin-
only proteins) are absent in mice, indicating that inflam-
masome-regulatory mechanisms have been subjected to differ-
ent selection pressures during co-evolution of the hosts with
their pathogens.
In addition to caspase-1, in vitro experiments indicated that
human caspase-4might process p62. Although the relevance of
this observation has not been tested in this study, itmay suggest
that p62 processing may also contribute to noncanonical
inflammasome activation in humans.
Mechanistic analyses further revealed that the cleavage of
human p62 by caspase-1 disrupts its normal interactions with
LC3B. Selective autophagy plays a key role in inflammasome
inactivation (8–11). p62 knockout cells and mice have an
increased response to inflammasome activation, as demon-
strated by increased release of IL-1 (8, 27). We sought to
determine whether cleavage of p62 at Asp-329 decreased or
enhanced its inhibitory role in inflammasome activation. We
thus overexpressed N-terminal and C-terminal fragments in
cells with various ratios and observed seemingly antagonist
effects of both fragments. Although the N-terminal fragment
strongly inhibited IL-1 release, the C-terminal fragment
increased cytokine release. For the latter, we observed an accu-
mulation of pro-IL-1, likely explaining its effects.Mechanistic
analyses demonstrated that only the N-terminal fragment was
able to bind the full-length p62 protein and that oligomeriza-
tion of p62 is required for its full adaptor function.We hypoth-
esize that the N-terminal p62 fragment may enhance p62 olig-
omerization, culminating in increased inhibitory effects on the
inflammasome complexes through autophagic degradation.
Figure 5. Caspase-1 cleavage disrupts p62 interaction with LC3B andmodulates IL-1 secretion. A, representation of the p62 structure. The PB1 (Phox
and Bem1) N-terminal domain allows p62 oligomerization and/or interactions with other autophagy adaptors. The LIR domain allows interaction with the
LC3B-coated compartment (autophagosome), and theUBAdomain binds ubiquitinated proteins. ZZ, ZZ-type zinc finger domain; TBS, TRAF6-bindingdomain;
KIR, KEAP1-interacting region. Alignment of the protein sequence surroundingAsp-329 demonstrates conservation in numerousmammalian species (human,
rat, bat (Myotis lucifugus), ferret (Mustela furo), cat (Felis catus), bovine) but not inmice. B, HEK293T cellswere cotransfectedwith plasmids encodingHA-tagged
WT p62 (WT-HA) or its uncleavable mutant (D329A-HA) along with the FLAG-tagged p62 N-terminal (N-FLAG) or C-terminal (C-FLAG) fragments and incubated
overnight. Cellswere thenwashed, lysed, and incubatedwith anti-HA–agaroseduring3hat 4 °C. Beadswere then rigorouslywashed, andboundproteinswere
analyzed by Western blotting. IP, immunoprecipitation. C, HEK293T cells were cotransfected with plasmids encoding HA-tagged caspase-1 (casp1-HA) and
FLAG-tagged p62N-terminal or C-terminal fragments and incubated overnight. Cells were thenwashed, lysed, and incubatedwith anti-FLAG–agarose during
3 h at 4 °C. Beads were rigorously washed, and bound proteins were analyzed by Western blotting. D, schematic presenting the interactions between p62
fragments and p62 full-length, caspase-1, and LC3B. E and F, WT iBMDMs were transduced stably with (E) the pINDUCER21 doxycycline-inducible lentiviral
vector encoding human p62 N-terminal or C-terminal fragments or transiently (F) with various ratios (1:1, 5:1, and 1:5) of the pINDUCER21 doxycycline-
inducible lentiviral vector encoding human p62 N-terminal (N) and C-terminal (C) fragments as indicated. Cells were incubated with doxycycline for 24 h (1
g/ml) to induce ectopic expression of p62 fragments. The inflammasome was then activated by addition of a priming signal (LPS, 1 g/liter during 3 h)
followedby either nigericin (5M, 45min),MSU (50g/ml, 6 h), or ATP (1mM, 60min) as indicated. The supernatantswere collected. IL-1 concentrationswere
measured by ELISA. *, p 0.05; **, p 0.001; ns, not significant.
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On the other hand, the C-terminal fragment, in addition to
precluding pro-IL-1 degradation by autophagy, is unable to
bind the full-length p62 proteins but retains the ability to bind
LC3B andmay act as a dominant-negative fragment, competing
with full-length p62 for LC3B binding to decrease p62-medi-
ated inhibition of the inflammasome. Indeed, such an effect has
already been reported for a longer p62 C-terminal fragment
cleaved at Gly-241 by a protease from Coxsackievirus (23, 28).
Coexpression of similar levels of N- and C-terminal frag-
ments led to decreased IL-1 release, suggesting a negative
dominant effect of the N-terminal fragment. Overall, these
results suggest that p62 is a complex regulator of the inflam-
masome with dual functions, either enhancing or quelling
inflammation (Fig. 6).
Conclusions
Using the BioID approach, we identified 111 proteins in close
proximity of caspase-1 during inflammasome activation; 75%of
them had not been related before to the inflammasome. p62,
which has been reported as a negative regulator of the inflam-
masome, is cleaved by caspase-1. Our results provide another
layer in the p62-mediated inflammasome regulation mecha-
nisms by showing that p62 cleavage by caspase-1 could either
result in inhibiting or increasing inflammasome activation.
Experimental procedures
Cell lines
iBMDMs fromWT or caspase-1/mice (a gift from D. M.
Monack and P. Broz, Stanford University, Stanford, CA) and
the humanmonocytic cell lines THP-1 andU937were cultured
in RPMI medium (Gibco) supplemented with 10% (v/v) FBS
and 1% penicillin/streptomycin. THP-1 and U937 cells were
grown in suspension in 75-cm2 flasks. HEK293T cells were
grown in Dulbecco’s modified Eagle’s medium (Gibco) supple-
mented with 10% (v/v) FBS, 4 mM L-glutamine, and 1% penicil-
lin/streptomycin. All cells were grown at 37 °C with 5% CO2.
Primary humanmonocytes andmacrophages
Healthy donor blood was provided by the Etablissement
Français du Sang in the Framework of Convention 14-1820.
Peripheral blood mononuclear cells were isolated by density
gradient centrifugation using lymphocyte separation medium
(Eurobio). Monocytes were isolated from peripheral blood
mononuclear cells by adhesion. Monocytes were differentiated
into macrophages by culture for 6 days in RPMI 1640 medium,
GlutaMAX medium (Thermo Fisher) supplemented with 10%
(v/v) FBS, and 50 ng/ml macrophage colony-stimulating factor
(Immunotools).
Reconstitution of caspase-1/ cells and generation of
HA-tagged BirA*–caspase-1–overexpressing cells
The lentiviral pINDUCER21 plasmid was obtained from
Steve Elledge (Harvard Medical School, Boston, MA) (41). A
human HA-tagged BirA*–caspase-1 construct was cloned into
the pENTR1A dual selection vector (Invitrogen) and then
cloned in the pINDUCER21, aGFPTet-inducible lentiviral vec-
tor plasmid. Lentiviruses were produced as described previ-
ously (42). Caspase-1/ andWT iBMDMs were infected with
HA-tagged BirA*–caspase-1–expressing lentiviruses. GFP-
positive cells were sorted by FACS 96 h post-infection. Cells
were cultured in complete medium, and HA-tagged BirA*–
caspase-1 expression was induced using tetracycline (doxycy-
cline, 1 g/ml) for 24 h.
Inflammasome activation
HA-tagged BirA*–caspase-1–expressing iBMDMs were cul-
tured to a density of about 1.5 106 cells/ml in 150-cm2 plastic
flasks or in 2-liter roller bottles. Inflammasome activation was
induced in a cell-free system as described previously (20).
When specified, biotinwas added before inflammasome activa-
tion at a final concentration of 50 M. For experiments using
non-cell-free inflammasome activation, cells were washed
twice with PBS, detached, enumerated, plated onto 12-well
plates, and left to adhere overnight. The following day, culture
media were changed before stimulation with Opti-MEM
(Gibco) for Western blot analysis or with complete culture
medium for ELISA analysis. Cells were primedwith 1g/ml for
3 h and stimulated with 5 M nigericin for 30 min, 50 g/ml of
MSU for 6 h, or 1mMATP for 60min. After stimulation, super-
natants were collected, and proteins were precipitated using
themethanol/chloroformmethod. Proteinswere then analyzed
by Western blot analysis after boiling and fractionation on a
15% SDS-polyacrylamide gel.
Streptavidin pulldown and identification of biotinylated
products byMS
Protein concentrations in supernatants from the cell-free
assay were determined using the Bradford protein assay (Bio-
Figure 6. A proposedmodel for p62 regulation of the inflammasome. In
the negative regulation model (left panel), caspase-1 cleavage of p62 and
subsequent release of the N-terminal fragment (1) may favor full-length p62
self-oligomerization (2), interaction with the LC3B-coated compartment (3),
and engulfment of the inflammasome into the autophagosome (4), allowing
quelling of the inflammation. In the positive regulation model (right panel),
caspase-1 cleavageof the entire p62poolmay alter p62 function andgive rise
to a dominant-negative C-terminal fragment (5) that competes with p62 for
LC3B binding (6) to inhibit autophagic degradation of pro-IL-1 and the
inflammasome (7), resulting in increased inflammasome activation, IL-1
release, and inflammatory cell death.
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Rad) and equalized in sample buffer. Supernatants were then
incubated with 30 l of Dynabeads (MyOne Streptavidin C1,
Invitrogen) overnight at 4 °C. Beads were collected and washed
twice for 8min at RT in 1ml of wash buffer (2% SDS in distilled
H2O). This was repeated with a wash buffer containing 0.1%
deoxycholate, 1% Triton X-100, 500 mM NaCl, 1 mM EDTA,
and 50 mM Hopes; then with a wash buffer containing 250 mM
LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA, and 10 mM
Tris (pH 8.1); and finally with a wash buffer containing 50
mMTris (pH 7.4) and 50mMNaCl. 10% of the sample was saved
for Western blot analysis. Bound proteins were removed from
the beads with 50 l of Laemmli SDS sample buffer at 98 °C.
Proteins eluted from the streptavidin beads by SDS sample
buffer were reduced, alkylated, and separated by 1D SDS-
PAGE. Mass spectrometry was performed as described previ-
ously (15, 43). The resulting .dat files were loaded into SCAF-
FOLD Q (Proteome Software). The acceptance level for
proteins was two identified peptides with minimum 95% prob-
ability each.
ASC oligomerization assay
After stimulation, the supernatant was removed, and cells
were detached with PBS containing 2 mM EDTA and centri-
fuged 5 min at 1500  g. Cells were lysed on ice in 500 l of
buffer A (20) by mechanical lysis (30 passages through a
21-gauge needle). The cell lysates were centrifuged in 1.5-ml
Eppendorf tubes at 1800 g for 8min to remove nuclei, and 30
l of the supernatants were kept for Western blot analysis to
test ASC expression in the lysates. The remaining supernatant
was diluted twice with buffer A and centrifuged for 5 min at
2000  g. After centrifugation, the supernatant was diluted
with 1 volume of CHAPS buffer (20mMHepes-KOH (pH7.5), 5
mM MgCl2, 0.5 mM EGTA, 0.1 mM phenylmethylsulfonyl fluo-
ride, and 0.1% CHAPS) and again centrifuged at 5000 g for 8
min to pellet the ASC pyroptosome. The supernatant was dis-
carded, and the pellet was resuspended in 50 l of CHAPS
buffer with 4mM of disuccinimidyl suberate (DSS, Thermo Sci-
entific) for 30 min at room temperature (RT). Samples were
centrifuged at 5000 g for 8min, and pellets were resuspended
in 30l of 2 loading buffer under nonreducing conditions for
Western blotting. For the cell-free assay, the ASC oligomeriza-
tion assay was performed as described previously (20).
Immunofluorescence staining and confocal microscopy
For confocal microscopy, primary monocytes were sorted
from healthy donor blood by sucrose gradient followed by
CD14-positive selection (Miltenyi Biotec) and cultured for 6
days in complete RPMI medium supplemented with human
macrophage colony-stimulating factor (100 ng/ml, Immunoto-
ols). Macrophages were plated the day before the experiment
on 15-mm coverslips in 12-well plates. After treatment, the
cells were fixed with 2% (v/v) paraformaldehyde (Applichem)
for 15 min at room temperature. The cells were then permea-
bilized with 0.1% Triton X-100 in PBS for 10 min and washed
once with PBS. The aspecific sites were blocked with 3% (w/v)
BSA prepared in PBS for 30 min at RT. Antibodies against
human p62 (Abcam) and human caspase-1 (Adipogen) were
diluted 1:500 in 1% BSA and incubated on the coverslips over-
night at 4 °C. Thenext day, the cellswerewashed five timeswith
PBS, and the fluorescent secondary antibodies (anti-IgG
(HL), Alexa Fluor conjugates, Thermo Scientific), diluted
1:1000 in 1% BSA, were applied for 1 h. The coverslips were
washed again with PBS and incubated for 5 min with Hoechst
dye diluted in PBS at a final concentration of 4 g/ml. The
coverslips were mounted on slides using ProLong Gold Anti-
fade (Invitrogen). Images were captured using an inverted con-
focal microscope (LSM 710 META, Zeiss) and processed with
Zeiss Axiovision software.
Mutagenesis
Point mutations were performed using the HA-p62 plasmid
(28027, Addgene) to obtain the p.[D329A] and p.[D347A]
mutants, using the QuikChangeTM site-directed mutagenesis
kit (Agilent Genomics), according to the manufacturer’s
instructions. The following primers (Microsynth AG) were
used: 5-GAA CAG ATG GAG TCG GCT AAC TGT TCA
GGA-3 and 5-TCC TGA ACA GTT AGC CGA CTC CAT
CTG TTC-3 for p62 D329A and 5-TCT TCA AAA GAA
GTG GCC CCG TCT ACA GGT GAA-3 and 5-TTC ACC
TGT AGA CGG GGC CAC TTC TTT TGA AGA-3 for p62
D347A.
Ectopic expression of p62 N-terminal and C-terminal
fragments in cells
p62 N-terminal and p62 C-terminal constructs were
obtained from the HA-p62 plasmid using the EcoR1 and NotI
restriction enzymes (New England Biolabs) and the following
primers (Microsynth AG): 5-AAAGAATTCATGGCCATG
TCC TAC GTG-3 and 5-AAA GCG GCC GCC TAC GAC
TCC ATC TGT TC-3 for p62 Nter and 5-AAA GAA TTC
AAC TGT TCA GGA GGA-3 and 5-AAA GCG GCC GCC
TAT CAC AAC GGC GGG-3 for p62 Cter. p62 N-terminal
andC-terminal constructswere then cloned into the pENTR1A
dual selection vector and then cloned into pINDUCER21. WT
iBMDMs were transduced with p62-expressing N-terminal or
C-terminal lentiviruses. The lentiviral load was quantified, and
different ratios were used to transduce the cells. GFP-positive
cells were sorted by FACS 96 h post-infection. Cells were cul-
tured in complete medium, and p62 fragment expression was
induced using doxycycline (1 g/ml) for 24 h. N- and C-termi-
nal fragment ratios were verified by Western blot analysis.
HEK293T transfection and co-immunoprecipitation
HEK293T cells were plated the day before the experiment,
transfected using polyethyleneimine, and incubated overnight
at 37 °C.The plasmids usedwere fromTschopp and co-workers
(2, 44, 45). N-terminal and C-terminal p62 constructs were
cloned into a FLAG tag–expressing plasmid on a PCR3 back-
bone. The HA-p62 plasmid was from Addgene (28027). For
co-transfection, the same amount of vector plasmid was trans-
fected in control cells. Cells (1  106) were then washed with
PBS, suspended in 200 l of lysis buffer (0.1% NP-40, 20 mM
Tris-HCl (pH 7.8), 150 mM NaCl, and 5 mM EDTA) supple-
mented with complete protease inhibitor (Roche), and incu-
bated on ice for 15min. Cells were then centrifuged at 1300 rpm
at 4 °C for 5min, and supernatant proteinswere quantified. The
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supernatants were either collected in Laemmli SDS buffer and
analyzed by Western blotting or incubated with 10 l of anti-
FLAG– or anti-HA–agarose (both from Sigma) at 4 °C over-
night under agitation. After centrifugation at 6000 rpm for 30
min, supernatants were discarded, and beads were washed five
times with lysis buffer. Immunoprecipitated material was
eluted in SDS sample buffer for 5 min at 100 °C and separated
with SDS-PAGE.
Western blotting
Proteins were denatured, separated by SDS-PAGE, and
transferred to nitrocellulose. Membranes were blocked in 2.5%
BSA in PBS with 0.4% Triton X-100 and incubated in the same
buffer with horseradish peroxidase–conjugated secondary
antibodies. Band intensities were quantified with ImageJ soft-
ware using arbitrary pixel intensity units.
ELISA
Cytokinereleasewasmeasured insupernatants fromstimulated
cells. Mouse IL-1 and human IL-1 ELISA kits (R&D Systems)
were used according to themanufacturer’s instructions.
Chemicals and antibodies
LPS, nigericin, ATP, calpain inhibitor, and doxycycline were
from Sigma. MSU crystals were prepared as described previ-
ously described (46). Z-YVAD-fmk, Z-VAD-fmk, and Z-IETD-
fmk were from Abcam. Anti-mouse caspase-1 p20, anti-mouse
and anti-human ASC antibody, anti-human caspase-1, and
anti-human tubulin were from Adipogen. Anti-mouse and
anti-human LC3B antibodies were from Sigma-Aldrich. Anti-
mouse and anti-human p62 and anti-HA tag antibodies were
fromAbcam. The anti-FLAG tag antibodywas fromGenScript.
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